Everett Harris & CO Gilead Sciences, Inc. Transaction History

Everett Harris & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	SELL	$73.27 - $83.09 $1,831 - $2,077	-25 Reduced 0.86%	2,869 $232,000
Q3 2023 Oct 23, 2023	SELL	$73.94 - $80.67 $38,744 - $42,271	-524 Reduced 15.33%	2,894 $216,000
Q2 2023 Jul 26, 2023	BUY	$76.01 - $86.7 $2,964 - $3,381	39 Added 1.15%	3,418 $263,000
Q4 2022 Jan 20, 2023	BUY	$62.32 - $89.47 $210,579 - $302,319	3,379 New	3,379 $0

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Everett Harris & CO , based on Form 13F filings with the SEC.

Stay updated on Everett Harris & CO with notifications on news.